RE: [External email] Sad news about Dr. Ludden

From: Stephen Duffull Date: August 04, 2024 news Source: mail-archive.com
I agree. While I only met Tom in person a few times we interacted quite a bit in my early days of PMx and NONMEM. Tom was immensely clever, kind, unassuming, understanding and supportive. A pleasure to chat with and to learn from. Steve Stephen Duffull Senior Scientific Advisor, Certara Drug Development Solutions [email protected]<mailto:[email protected]> Dunedin, Aotearoa New Zealand (NZ Time Zone: UTC +12) http://www.certara.com/ [cid:[email protected]]
Quoted reply history
From: [email protected] <[email protected]> On Behalf Of Paul Hutson Sent: Sunday, August 4, 2024 3:32 AM To: Ekaterina Gibiansky <[email protected]>; Diane Mould <[email protected]>; Riley, Steve <[email protected]>; [email protected] Subject: RE: [External email][NMusers] Sad news about Dr. Ludden Some people who received this message don't often get email from [email protected]<mailto:[email protected]>. Learn why this is https://aka.ms/LearnAboutSenderIdentification CAUTION: This email originated from outside of Certara. Do not click links or open attachments unless you recognize the sender and know the content is safe. What a giant. I always appreciated his kindness in responding to my naiive questions about coding NONMEM. Paul R. Hutson, PharmD, BCOP Professor (CHS) UW School of Pharmacy Director, UW Madison Transdisciplinary Center for Research in Psychoactive https://www.research.pharmacy.wisc.edu/tcrps Faculty Leader, Paul P. Carbone Comprehensive Cancer Center Cancer Pharmacology https://cancer.wisc.edu/research/resources/ddc/cancer-pharmacology/ T: 608.263.2496 [email protected]<mailto:[email protected]> From: [email protected]<mailto:[email protected]> <[email protected]<mailto:[email protected]>> On Behalf Of Ekaterina Gibiansky Sent: Friday, August 2, 2024 3:19 PM To: Diane Mould <[email protected]<mailto:[email protected]>>; Riley, Steve <[email protected]<mailto:[email protected]>>; [email protected]<mailto:[email protected]> Subject: Re: [External email][NMusers] Sad news about Dr. Ludden I second everything Steve, and Mark, and Diane said. All of us who were blessed to work alongside him will forever remember him with fondness and gratitude. And let's not forget that he was the only one who Stuart Beal trusted to take care of NONMEM and bring it forward into 21st century. Katya On 8/2/2024 3:55 PM, Diane Mould wrote: Dear All I am very saddened to hear this news. Tom Ludden was one of the nicest and smartest people that I have ever known. He was a gentle giant in our field and I will miss him. Best Diane From: [email protected]<mailto:[email protected]> <[email protected]><mailto:[email protected]> On Behalf Of Riley, Steve Sent: Friday, August 2, 2024 2:41 PM To: [email protected]<mailto:[email protected]> Subject: [External email][NMusers] Sad news about Dr. Ludden CAUTION: This email originated from outside the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe. Dear NM-Users, Regrettably, I am writing to let you know that Dr. Ludden passed away Tuesday evening, 30JUL2024. I was able to get there over the weekend prior to visit him and his family. During his wakeful moments we had some good scientific discussions. We talked a lot about NONMEM and how its functionality and utility has expanded since he retired. He was pleased to hear about the changes. He was surrounded by family for the days leading up to the end. They were all appreciative that I was able to get there and tell him (and them) how much he meant to all of us and the impact he had on our careers. I think memories of Dr. Ludden were characterized perfectly by Marc Gastonguay, "I am forever grateful for the positive impact that Tom had on my life and career, not to mention the tremendous, although often underappreciated, contributions he made to the disciplines of clinical pharmacology and pharmacometrics. His humble brilliance will be missed and fondly remembered." Steve Riley This message (including any attachments) may contain confidential, proprietary, privileged and/or private information. The information is intended to be for the use of the individual or entity designated above. If you are not the intended recipient of this message, please notify the sender immediately, and delete the message and any attachments. Any disclosure, reproduction, distribution or other use of this message or any attachments by an individual or entity other than the intended recipient is prohibited.
Aug 02, 2024 Steve Riley Sad news about Dr. Ludden
Aug 02, 2024 Diane Mould RE: [External email] Sad news about Dr. Ludden
Aug 02, 2024 Ekaterina Gibiansky Re: [External email] Sad news about Dr. Ludden
Aug 02, 2024 Ene Ette RE: [External email] Sad news about Dr. Ludden
Aug 02, 2024 Sujatha S Menon Re: [EXTERNAL] Re: [External email] Sad news about Dr. Ludden
Aug 02, 2024 Robert Bauer Sad news about Dr. Ludden
Aug 02, 2024 Bela Patel RE: [External email] Sad news about Dr. Ludden
Aug 03, 2024 Nick Holford RE: Sad news about Dr. Ludden
Aug 03, 2024 Mark Sale RE: Sad news about Dr. Ludden
Aug 03, 2024 Joga Gobburu Re: Sad news about Dr. Ludden
Aug 03, 2024 Paul Hutson RE: [External email] Sad news about Dr. Ludden
Aug 03, 2024 Alison Boeckmann Re: Sad news about Dr. Ludden
Aug 04, 2024 Stephen Duffull RE: [External email] Sad news about Dr. Ludden
Aug 05, 2024 Rene Bruno Re: Sad news about Dr. Ludden
Aug 06, 2024 Vijay Ivaturi Re: Sad news about Dr. Ludden